GlassScriptPhysician profile
Lauren E Miller
NPI 1194010066
$1,417.96
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $239 · 2021: $145 · 2022: $376 · 2023: $228 · 2024: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $474.88 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $198.52 | 2019-2024 | Gardasil 9, M-M-R II, Vaxneuvance |
| Kaleo, INC. | $139.64 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $85.56 | 2022-2023 | Flumist Quadrivalent |
| Glaxosmithkline, LLC. | $83.90 | 2019-2021 | |
| Ironshore Pharmaceuticals INC. | $63.61 | 2021-2024 | Jornay Pm |
| Qol Medical, LLC | $62.17 | 2023 | Sucraid |
| Takeda Pharmaceuticals U.S.A., INC. | $61.80 | 2020-2022 | |
| Hologic Sales and Service, LLC | $47.36 | 2024 | Aptima |
| Sanofi Pasteur INC. | $43.31 | 2022-2024 | |
| Sobi, INC | $40.73 | 2019 | |
| Phadia US INC. | $33.59 | 2024 | Immunocap |
| Seqirus USA INC | $32.10 | 2022 | |
| Mylan Pharmaceuticals INC. | $30.81 | 2019 | |
| Cranial Technologies, INC | $19.98 | 2024 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.